cinacalcet - OmicsDI

Show results for

Unknown (151)
Metabolomics (9)
Transcriptomics (7)
Genomics (5)
Proteomics (2)

Organisms

Mus musculus (4)
Homo sapiens (2)
Alphavirus (2)
Archaea (2)
Bacteria (2)
Betaherpesvirinae (2)
Borrelia (2)
Botrytis cinerea (2)
Chlorella vulgaris (2)
Clostridium perfringens (2)
Eukaryota (2)
Fungi (2)
Hepatitis B virus (2)
Human betaherpesvirus 5 (2)
Influenza A virus (2)
Influenza C virus (2)
Japanese encephalitis virus group (2)
Mammarenavirus (2)
Miscanthus x giganteus (2)
Mycobacterium tuberculosis (2)
Orthoflavivirus (2)
Panicum virgatum (2)
Pseudomonas aeruginosa (2)
Rattus (2)
Saccharomyces cerevisiae (2)
Schizosaccharomyces (2)
Schizosaccharomyces pombe (2)
Severe acute respiratory syndrome coronavirus 2 (2)
Staphylococcus aureus (2)
Rattus norvegicus (1)

Organisms

Mus musculus (2)
Staphylococcus aureus (1)
Rattus norvegicus (1)
Homo sapiens (1)

Repository

MetaboLights (9)
ENA (5)
geo (4)
biostudies-arrayexpress (3)
pride (2)

Tissue

Cell culture (1)

Disease

Nephrotic syndrome (1)

Technology Type

Mass spectrometry (6)
Mass spectrometry assay (3)
Mass Spectrometry (2)
SWATH MS (1)
Shotgun proteomics (1)

Instrument Platform

Liquid Chromatography MS - negative - reverse phase (4)
Liquid Chromatography MS - positive - reverse phase (4)
Liquid Chromatography MS - alternating - reverse-phase (2)
Liquid Chromatography MS - positive - direct infusion (1)
Liquid Chromatography MS - negative - direct infusion (1)
Liquid Chromatography MS - negative - reversed-phase-chromatography (1)
Gas Chromatography MS - positive (1)
Liquid Chromatography MS - positive - reverse-phase (1)
Liquid Chromatography MS - negative - reverse-phase (1)
Liquid Chromatography MS - negative - hilic (1)
Liquid Chromatography MS - positive - hilic (1)

Publication Date

2026 (4)
2022 (4)
2016 (3)
2025 (3)
2024 (2)
2019 (1)
2023 (1)

CHEBI ID

CHEBI:48390 (3)
CHEBI:80157 (3)
CHEBI:89951 (3)
CHEBI:138785 (3)
CHEBI:28919 (3)
CHEBI:16418 (3)
CHEBI:18015 (3)
CHEBI:9728 (3)
CHEBI:6257 (3)
CHEBI:36790 (3)
CHEBI:169001 (3)
CHEBI:7769 (3)
CHEBI:135679 (3)
CHEBI:28283 (3)
CHEBI:69080 (3)
CHEBI:4653 (3)
CHEBI:15353 (3)
CHEBI:50381 (3)
CHEBI:18157 (3)
CHEBI:15905 (3)
CHEBI:72741 (3)
CHEBI:131743 (3)
CHEBI:131690 (3)
CHEBI:75036 (3)
CHEBI:75455 (3)
CHEBI:2877 (3)
CHEBI:168693 (3)
CHEBI:8087 (3)
CHEBI:18101 (3)
CHEBI:17256 (3)

Metabolite Name

Cinacalcet (9)
Thymidine (9)
Beta-D-3-Ribofuranosyluric acid (7)
Biliverdin (7)
N-Lauroylglycine (7)
N-Undecanoylglycine (7)
Sorbitan laurate (7)
Bortezomib (6)
Tridecanoylglycine (6)
3-Hydroxytetradecanedioic acid (6)
Dehydroepiandrosterone sulfate (6)
Methyl linoleate (6)
Sebacic acid (6)
Adenosine (6)
Suberic acid (6)
Riboflavin (6)
L-Tryptophan (6)
Dodecanedioic acid (6)
Uric acid (6)
Guanosine (6)
L-Phenylalanine (6)
LysoPE(0:0/15:0) (5)
(R)-1-O-[b-D-Glucopyranosyl-(1->6)-b-D-glucopyranoside]-1,3-octanediol (5)
Drotaverine (5)
7-Hydroxy-6-methyl-8-ribityl lumazine (5)
6-Hydroxypentadecanedioic acid (5)
Blasticidin S (5)
Gamma-Glutamylphenylalanine (5)
6-Ketomyristic acid (5)
LysoPE(0:0/16:0) (5)

First Public Date

2022 (2)
2026 (1)
2024 (1)
2019 (1)

Classification

bacteria (1)

Study type

Transcription profiling by array (3)

Release Date

2019 (17)
2024 (16)
2016 (14)
2022 (14)
2021 (14)
2018 (13)
2020 (11)
2015 (10)
2023 (9)
2025 (8)
2017 (8)
2012 (7)
2014 (4)
2011 (3)
2010 (3)
2013 (2)
2009 (1)

Lab affiliation

III. Department of Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (1)
MOE Key Laboratory of Tumor Molecular Biology and Key Laboratory of Functional Protein Research of Guangdong Higher Education Institutes, Institute of Life and Health Engineering, College of Life Science and Technology, Jinan University, Guangzhou, China (1)

Tags

xref:PubMed:35457141 (1)
xref:PubMed:39761264 (1)
xref:PubMed:42268882 (1)
pathogen (1)
pathogen:bacterium (1)

Previous page
1 / 18
You're on page 1
page 2
page 3
page 4
page 5
page ...
page 18
Next page

Sort by:

Relevance

Page size

Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial.

Not available

S-EPMC4338730 | biostudies-literature

Effect of cinacalcet HCL on gene expression in mouse kidney

PRJNA449102 | ENA

Effects of Cinacalcet on Fracture Events in Patients Receiving Hemodialysis: The EVOLVE Trial.

Not available

S-EPMC4446874 | biostudies-literature

Parathyroid tissue transcriptome of control, untreated uremic and Cinacalcet-treated uremic rats at two timepoints

We investigate whether Cinacalcet treatment timed to the expression of its drug target; the Calcium-Sensing Receptor, could improve efficacy of treatment in secondary hyperparathyroidism. We found that proliferation rate of parathyroid glands of uremic rats was markedly reduced when Cinacalcet was a...

ORGANISM(S): Rattus norvegicus

2024-12-19 | GSE227079 | GEO

Parathyroid tissue transcriptome of control, untreated uremic and Cinacalcet-treated uremic rats at two timepoints

PRJNA943183 | ENA

Pharmacogenetic analysis of cinacalcet response in secondary hyperparathyroidism patients.

Not available

S-EPMC4944925 | biostudies-literature

Cinacalcet lowering of serum fibroblast growth factor-23 concentration may be independent from serum Ca, P, PTH and dose of active vitamin D in peritoneal dialysis patients: a randomized controlled study.

Not available

S-EPMC3669111 | biostudies-literature

Cinacalcet and primary hyperparathyroidism: systematic review and meta regression.

Not available